Characteristics | Number of patients | |||
---|---|---|---|---|
 | Total | ATP7A(-) | ATP7A(+) | P |
Age | ||||
   median | 57 | 57 | 57 |  |
   range | 31-79 | 35-79 | 31-77 | 0.469 |
Gender | ||||
   male | 64 | 39 | 25 |  |
   female | 25 | 13 | 12 | 0.442 |
Response to chemo | ||||
   PR | 29 | 24 | 5 |  |
   SD+PD | 60 | 28 | 32 | 0.001 |
Stage | ||||
   III | 48 | 28 | 20 |  |
   IV | 41 | 24 | 17 | 0.436 |
PS | ||||
   0 | 46 | 29 | 17 |  |
   > 0 | 43 | 23 | 20 | 0.361 |
Histology | ||||
   squamous | 25 | 14 | 11 |  |
   adenocarcinoma | 64 | 39 | 25 | 0.67 |
Grade | ||||
   low | 48 | 28 | 20 |  |
   moderate | 27 | 12 | 15 |  |
   high | 14 | 12 | 2 | 0.039 |
CEA status | ||||
   normal | 34 | 18 | 16 |  |
   elevated | 55 | 34 | 21 | 0.661 |